Also listed on FTF Pharma Private Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jun 7, 2037 · Medium confidence
20-year base term ends Jun 7, 2037
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 12,168,069), so the cap could be lower.
Jun 7, 2017
Jun 7, 2037
Apr 14, 2026
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 7, 2017, when application PCT/IB2017/053348, the earliest non-provisional in its chain, was filed (this one was filed Jun 30, 2025) | Jun 7, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,369,567, US 11,654,106, US 11,925,704, US 12,168,069, US 12,370,136) | resolves to Jun 7, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 7, 2037 | Medium confidence |
This family
| US 11,369,567 | In force Jun 2037 | Jun 2037 |
| US 11,654,106 | In force Jun 2037 | Jun 2037 |
| US 11,925,704 | In force Jun 2037 | Jun 2037 |
| US 12,168,069 | In force no later than Jun 2037 | no later than Jun 2037 |
| US 12,370,136 | In force Jun 2037 | Jun 2037 |
| US 12,599,553 | this patent Jun 2037 | Jun 2037 |
| US 12,758,492 | In force Jun 2037 | Jun 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 21, 2025 Reel 71773, frame 935 | FTF Pharma Private Limited | Liqmeds Worldwide Limited | Assignment of Assignor's Interest |
| Jul 21, 2025 Reel 72101, frame 724 | Mehta, Sandip P.; Patel, Henil Alpeshbhai; Mandal, Jayanta Kumar | FTF Pharma Private Limited; Liqmeds Worldwide Limited | Assignment of Assignor's Interest |
| Jul 21, 2025 reel/frame not recorded | Mandal, Jayanta Kumar; Mehta, Sandip P.; Patel, Henil Alpeshbhai | FTF Pharma Private Limited | Assignment of Assignor's Interest |
| Jul 21, 2025 reel/frame not recorded | Mandal, Jayanta Kumar; Mehta, Sandip P.; Patel, Henil Alpeshbhai | Liqmeds Worldwide Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,369,567, US 11,654,106, US 11,925,704, US 12,168,069, US 12,370,136, ends no earlier than this term, so it caps nothing.